SPDR S&P Pharmaceuticals ETF
XPH
XPH
85 hedge funds and large institutions have $205M invested in SPDR S&P Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 9 closing their positions.
Holders
85
Holders Change
+15
Holders Change %
+21.43%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
21
Reduced
16
Closed
9
Calls
$1.14M
Puts
$316K
Net Calls
+$825K
Net Calls Change
+$1.35M
Top Buyers
1 |
1
HighTower Advisors
Chicago,
Illinois
|
$15.9M |
2 |
2
Morgan Stanley
New York
|
$42.7M |
3 |
3
Lazard Asset Management
New York
|
$7.54M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$5.78M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$6.69M |